Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,690 across all filing types
Latest filing 2018-04-20 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
内部审计制度（2018年4月）
Regulatory Filings Classification · 95% confidence The document is titled '内部审计制度' (Internal Audit System) of 迪瑞医疗科技股份有限公司 and details the internal audit policies, responsibilities, procedures, and organizational structure. It is a regulatory or governance-related document outlining internal audit rules rather than a financial report or announcement. It does not contain financial statements, earnings data, or voting results. It is not a report publication announcement since it is substantive and detailed. The content aligns with governance or audit-related information but is not a standalone audit report or audit results. Given the nature of the document as an internal audit system policy, it best fits under Regulatory Filings (RNS) as a compliance and regulatory document that does not fit other specific categories.
2018-04-20 Chinese
董事、监事和高级管理人员持有和买卖本公司股票管理制度（2018年4月）
Governance Information Classification · 95% confidence The document is a detailed internal policy and management system regarding the holding and trading of company shares by directors, supervisors, and senior management personnel of the company. It includes rules on information disclosure, share transfer restrictions, lock-up periods, responsibilities, and penalties related to insider trading and share transactions by key company personnel. The document references relevant laws and regulatory requirements, and includes forms for reporting share transactions and declarations. It does not contain financial statements, earnings data, or audit information. It is not an announcement or a brief summary but a comprehensive governance document focused on insider shareholding and trading management. Therefore, it fits best under the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2018-04-20 Chinese
2017年度财务决算报告
Annual Report Classification · 95% confidence The document is titled as the "2017 Annual Financial Settlement Report" of Dirui Medical Technology Co., Ltd. It contains detailed financial statements including balance sheets, profit and loss statements, cash flow statements, and notes for the fiscal year ending December 31, 2017. The report includes audited financial data with an unqualified audit opinion from Ruihua Certified Public Accountants. It provides comprehensive financial analysis, changes in assets, liabilities, equity, and detailed explanations of financial results and cash flows. The document length is 6843 characters, which is sufficient to contain substantive financial data rather than just an announcement. The content matches the characteristics of an official yearly report covering company activity and full financial performance, consistent with an Annual Report (10-K) filing type. FY 2017
2018-04-20 Chinese
2017年度监事会工作报告
Management Reports Classification · 95% confidence The document is titled as the Supervisory Board Work Report for the year 2017 of a company. It details the supervisory board's activities, meetings, opinions on company operations, financial status, internal controls, related party transactions, and plans for the next year. It references the audit report but does not contain the audit report itself. The document is a formal report by the supervisory board summarizing their oversight work for the year, which is a type of management or supervisory report rather than a full annual report or audit report. It is not an announcement or a brief notice but a substantive report on supervisory activities. Therefore, the best fitting category is Management Reports (MDA).
2018-04-20 Chinese
2017年度董事会工作报告
Management Reports Classification · 95% confidence The document is titled '2017 年度董事会工作报告' which translates to '2017 Annual Board of Directors Work Report'. It contains a detailed review of the company's operating performance, market marketing, R&D team, investment projects, internal governance, and future development outlook for the year 2017. It also includes information about board meetings and shareholders' meetings held during the year. The content is comprehensive and covers management's explanation of financial results, business trends, and outlook. This matches the characteristics of a Management Reports (MDA) filing, which provides detailed management commentary on the company's performance and outlook. The document is not a full annual report (10-K) as it lacks full financial statements, nor is it an announcement or a certification. Therefore, the appropriate classification is MDA with high confidence.
2018-04-20 Chinese
关于变更会计政策的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the company about a change in accounting policies, referencing specific accounting standards issued by the Ministry of Finance and describing the impact of these changes on prior financial statements. It includes details about the board meeting resolution approving the change. The document is relatively short (1554 characters) and does not contain full financial statements or comprehensive financial data. It is not a full annual or interim report, nor an audit report. Instead, it is a regulatory announcement about accounting policy changes approved by the board. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such announcements that do not constitute full reports.
2018-04-20 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.